June 10, 2009

Effect of dipyridamole plus aspirin on hemodialysis graft patency

.   .   

This randomized controlled trial provides evidence that treatment with dipyridamole plus aspirin had a modest effect in reducing the risk of stenosis and improving the duration of primary unassisted patency of newly created grafts.

View the Accompanying editorial by C Lok
Antiplatelet therapy and vascular-access patency.
N Engl J Med. 2009 May 21;360(21):2240-2.

Related Articles:

Hemodialysis, Vascular Access
  • Sarah Jennings

    While the intervention is simple and safe, I question whether this is an intervention which should actually change practice. The intervention simply delayed access complications rather than eliminating them and comes with a not insignificant cost.